Genetically Engineered Mouse Models of Prostate Cancer

Slides:



Advertisements
Similar presentations
Copyright © 2005 Brooks/Cole — Thomson Learning Biology, Seventh Edition Solomon Berg Martin Chapter 13 Gene Regulation.
Advertisements

Next lecture:techniques used to study the role of genes in develpoment Random genetics followed by screening Targeted mutagenesis (gene knockout) Transgenic.
Transgenic Mouse: Generic term for an engineered mouse that has a normal DNA sequence for a gene replaced by an engineered sequence or a sequence from.
Knockout and transgenic mice: uses and abuses
Chapter 12 DNA, RNA, Gene function, Gene regulation, and Biotechnology.
Complexities of Gene Expression Cells have regulated, complex systems –Not all genes are expressed in every cell –Many genes are not expressed all of.
1 Coding region ATG: Translation start Translation stop Transcription start (mRNA start) (mRNA end) poly-adenylation exon intron Mature mRNA Gene structure.
KEY CONCEPT Gene expression is carefully regulated in both prokaryotic and eukaryotic cells. Chapter 11 – Gene Expression.
Schematic representation of mechanisms of activation of a host gene by insertion of a provirus and the general structure of leukemia and leukosis and acute.
Allan Balmain, Hiroki Nagase  Trends in Genetics 
Genetically Engineered Mouse Models of Prostate Cancer
Haydn Prosser, Sohaila Rastan  Trends in Biotechnology 
Lesson Four Structure of a Gene.
Lesson Four Structure of a Gene.
A Robust Network of Double-Strand Break Repair Pathways Governs Genome Integrity during C. elegans Development  Daphne B. Pontier, Marcel Tijsterman 
Koen J.T. Venken, Julie H. Simpson, Hugo J. Bellen  Neuron 
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
Volume 140, Issue 2, Pages e2 (February 2011)
Concept 18.2: Eukaryotic gene expression can be regulated at any stage
Volume 56, Issue 2, Pages (August 2009)
Mouse Models in Preclinical Studies for Pachyonychia Congenita
The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis by Hongmin Sun, Tony L. Yang, Angela.
Counselling the Prostate Cancer Patient
What We Have Learned About Pancreatic Cancer From Mouse Models
Volume 74, Issue 4, Pages (August 2008)
Rationale for generation of reporter fusions by Red-mediated recombination. Rationale for generation of reporter fusions by Red-mediated recombination.
Volume 28, Issue 3, Pages (March 2008)
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Developmentally Programmed Rearrangement of T Cell Receptor Vγ Genes Is Controlled by Sequences Immediately Upstream of the Vγ Genes  Jeanne E Baker,
Transgenic Mouse Technology in Skin Biology: Generation of Knockin Mice  Frederik Tellkamp, Farida Benhadou, Jeroen Bremer, Maria Gnarra, Jana Knüver,
Transgenic Mouse Technology in Skin Biology: Generation of Complete or Tissue- Specific Knockout Mice  Lukas Scharfenberger, Tina Hennerici, Gábor Király,
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 154, Issue 6, Pages (September 2013)
RBM24 Is a Major Regulator of Muscle-Specific Alternative Splicing
E.N Olson, H.-H Arnold, P.W.J Rigby, B.J Wold  Cell 
Supplemental Figure 3 A B C T-DNA 1 2 RGLG1 2329bp 3 T-DNA 1 2 RGLG2
The gene trap resource: A treasure trove for hemopoiesis research
Volume 18, Issue 2, Pages (April 2005)
Volume 22, Issue 9, Pages (February 2018)
Molecular Neuroanatomy's “Three Gs”: A Primer
Induced pluripotent stem cells: A new era for hepatology
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal  Jane Jialu Xu, Monique F. Smeets, Shuh Ying Tan, Meaghan Wall,
Naokazu Inoue, Ph. D. , Takao Nishikawa, M. S. , Masahito Ikawa, Ph. D
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 3, Issue 1, Pages 1-7 (January 2013)
The Bare Lymphocyte Syndrome: Molecular Clues to the Transcriptional Regulation of Major Histocompatibility Complex Class II Genes  Angela DeSandro, Uma.
Jaimie M. Van Norman, Rebecca L. Frederick, Leslie E. Sieburth 
Paramutation: From Maize to Mice
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer  Ramprasath Venkatachalam  Gastroenterology 
Volume 9, Issue 4, Pages (November 2014)
Koen J.T. Venken, Julie H. Simpson, Hugo J. Bellen  Neuron 
Volume 4, Issue 2, Pages (August 2008)
Volume 128, Issue 1, Pages 9-13 (January 2007)
Cancer Modeling in the Modern Era
Volume 10, Issue 4, Pages (October 2004)
It takes two to Twist Kidney International
Targeted Genome Editing in Genes and cis-Regulatory Regions Improves Qualitative and Quantitative Traits in Crops  Xitao Li, Yongyao Xie, Qinlong Zhu,
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
Generation of Siva conditional knockout mice.
Volume 17, Issue 2, Pages (August 2015)
Figure 1. Kidney-Specific Cre/loxP Recombination.
Fig. 1. Generation of WNK3 knockout mice
Andrew Peters, Ursula Storb  Immunity 
Generation of an inducible tissue-specific Atoh1 transgenic mouse line
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
CTCF regulates cell cycle progression of αβ T cells in the thymus
New Tools for Genome Modification in Human Embryonic Stem Cells
Volume 12, Issue 6, Pages (December 2007)
Presentation transcript:

Genetically Engineered Mouse Models of Prostate Cancer Martijn C. Nawijn, Andreas M. Bergman, Henk G. van der Poel  European Urology Supplements  Volume 7, Issue 8, Pages 566-575 (August 2008) DOI: 10.1016/j.eursup.2008.01.019 Copyright © 2008 European Association of Urology and European Board of Urology Terms and Conditions

Fig. 1 Genetic engineering of the mouse germline. Most genes present in the mouse genome will contain several exons, indicated as open rectangles, spaced by the noncoding intervening sequences known as introns. Gene expression is controlled by regulatory sequences positioned upstream of the transcription initiation site (both enhancer and promoter sequences), in the intronic sequences or downstream of the last exon (depicted schematically as the black arrow). (B) Single gene knockouts are generated by replacing most of the coding sequences, or a critical part of the coding sequence, by unrelated sequences. Expression from the endogenous locus will result in a nonfunctional protein. The knockout allele is often referred to as a null allele. (C) Multicopy transgenics are generated by genomic insertion of multiple copies of a transgene, usually the cDNA sequence of the gene of interest (indicated as the fused open rectangles) placed under transcriptional regulation of a generic or cell-type specific promoter sequence (indicated by the grey arrow). Transgene integration occurs at a random position in the genome, and copy numbers vary between individual founder mice, allowing for the selection of high- and low-copy transgenic strains. (D) Conditional knockout strains are generated by the introduction of loxP sequences (indicated as solid triangles) at opposite ends of the gene of interests. Expression (usually transgenic) of the Cre recombinase will result in fusion of the two loxP sites, with excision of the intervening sequences, in this case most of the coding sequence of the gene. Hence, a conditional knockout allele allows the normal developmental expression pattern of the gene up to the moment when Cre recombinase is introduced into the (somatic) cells. Depending on the expression pattern of the Cre transgene, this approach allows the generation of tissue-specific knockouts. (E) Conditional transgenic strains are generated by the introduction of a conditional STOP cassette upstream of the coding sequences of the transgene of interest. The STOP cassette abrogates translation from the mRNA and precludes expression of the transgene. Introduction of Cre recombinase results in removal of the STOP cassette and thereby induces expression of the transgene. The expression pattern of the Cre recombinase determines the tissue-specific activation of the transgene. European Urology Supplements 2008 7, 566-575DOI: (10.1016/j.eursup.2008.01.019) Copyright © 2008 European Association of Urology and European Board of Urology Terms and Conditions